Saturday, February 27
Shadow
Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnson’s Covid-19 vaccine was endorsed on Friday by a panel of experts advising the Food and Drug Administration, clearing the last hurdle before a formal authorization expected on Saturday, according to two people familiar with the agency’s plans. The nation’s first shipments will go out in the days after that. It will be the third shot made available to the United States in the year since the first surge of coronavirus cases began washing over the country, and it will be the first vaccine to require just one dose instead of two. Johnson & Johnson’s formulation worked well in clinical trials, particularly against severe disease and hospitalizations, even though it did not match the sky-high efficacy rates of the first two vaccines made by Pfizer-BioNTech and Moderna. ...
Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnson’s Covid-19 vaccine was endorsed on Friday by a panel of experts advising the Food and Drug Administration, clearing the last hurdle before a formal authorization expected on Saturday, according to two people familiar with the agency’s plans. The nation’s first shipments will go out in the days after that. It will be the third shot made available to the United States in the year since the first surge of coronavirus cases began washing over the country, and it will be the first vaccine to require just one dose instead of two. Johnson & Johnson’s formulation worked well in clinical trials, particularly against severe disease and hospitalizations, even though it did not match the sky-high efficacy rates of the first two vaccines made by Pfizer-BioNTech and Moderna. ...
Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnson’s Covid-19 vaccine was endorsed on Friday by a panel of experts advising the Food and Drug Administration, clearing the last hurdle before a formal authorization expected on Saturday, according to two people familiar with the agency’s plans. The nation’s first shipments will go out in the days after that. It will be the third shot made available to the United States in the year since the first surge of coronavirus cases began washing over the country, and it will be the first vaccine to require just one dose instead of two. Johnson & Johnson’s formulation worked well in clinical trials, particularly against severe disease and hospitalizations, even though it did not match the sky-high efficacy rates of the first two vaccines made by Pfizer-BioNTech and Moderna. ...
Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnsons Vaccine Could Get FDA Green Light on Saturday – msnNOW

Johnson & Johnson’s Covid-19 vaccine was endorsed on Friday by a panel of experts advising the Food and Drug Administration, clearing the last hurdle before a formal authorization expected on Saturday, according to two people familiar with the agency’s plans. The nation’s first shipments will go out in the days after that. It will be the third shot made available to the United States in the year since the first surge of coronavirus cases began washing over the country, and it will be the first vaccine to require just one dose instead of two. Johnson & Johnson’s formulation worked well in clinical trials, particularly against severe disease and hospitalizations, even though it did not match the sky-high efficacy rates of the first two vaccines made by Pfizer-BioNTech and Moderna. ...
CDC director warns decline in COVID-19 cases may be stalling in concerning shift | TheHill – The Hill

CDC director warns decline in COVID-19 cases may be stalling in concerning shift | TheHill – The Hill

Centers for Disease Control and Prevention (CDC) Director Rochelle WalenskyRochelle WalenskyNew COVID-19 cases among nursing home residents fell 80 percent in a month Poll: Majority say teachers should be vaccinated before reopening schools New Yorkers should double mask until at least June, de Blasio says MORE warned Friday that recent declines in COVID-19 cases, hospitalizations and deaths "may be stalling," calling the trends a "very concerning shift." CDC data shows the number of new cases has declined dramatically in recent weeks, from a peak of about 250,000 per day in mid-January to about 60,000 per day. But now after weeks of falling, the number of new cases has started ticking back up in recent days, and are still at a very high level overall, at about 66,000 new cases per ...
OSDH: 867 new COVID-19 cases reported in Oklahoma – KFOR Oklahoma City

OSDH: 867 new COVID-19 cases reported in Oklahoma – KFOR Oklahoma City

OKLAHOMA CITY (KFOR) – Health officials are reporting 18 additional deaths connected to COVID-19 in Oklahoma, but say most of those deaths occurred last year. On Friday, data from the Oklahoma State Department of Health shows that the state has had 423,023 confirmed cases of COVID-19 since March of 2020. That’s an increase of 867 cases or a 0.2% increase. There were 18 additional deaths caused by the virus, bringing the state’s total number of deaths to 4,320. Officials say 2 of the newly reported deaths occurred since Jan. 1. Hannah White is the first Oklahoman to receive the vaccine. White is an emergency room Registered Nurse.At this point, officials say there are 571 patients hospitalized with a confirmed case of COVID-19. So far, the state report...
Indian slum residents unknowingly part of COVID-19 vaccine trial – Insider

Indian slum residents unknowingly part of COVID-19 vaccine trial – Insider

A white van drove through the slums of Bhopal in central India advertising a COVID-19 vaccine. The van reportedly said that anyone who got one would receive 750 rupees. But according to CNN, the residents were unknowingly part of a vaccine trial. Visit Insider's homepage for more stories. It seemed like a win-win for residents in the slums of Bhopal in central India when a white van drove through the streets advertising, "Come and take the coronavirus vaccine and get 750 rupees!" from its speaker system. But according to a new report from CNN, the shots doled out were actually a part of the third phase of India's Covaxin clinical trials...
If someone in your household has COVID-19, theres only a 1-in-10 chance youll catch it too – Daily Mail

If someone in your household has COVID-19, theres only a 1-in-10 chance youll catch it too – Daily Mail

If someone in your household has COVID-19, there's only a 1-in-10 chance you'll catch it too, study finds Researchers in Boston studied more than 7,000 homes with a Covid case   Found that of all the people who lived with them only 10.1% got infected   Study also found risk of catching it at home from someone you live with rises for people with preexisting health conditions   By Joe Pinkstone For Mailonline Published: 19:05 GMT, 26 February 2021 | Updated: 19:05 GMT, 26 February 2021 Just one in ten people who catch Covid pass it on to someone they live with, a study has found.  US researchers analysed data from more than 7,000 homes in Boston and found more than 25,000 people lived there between March 4 and May 17, 2020. In this time frame 7,262 people ca...
Health officials warn of possible COVID-19 exposure at Plattsburgh bar – WPTZ

Health officials warn of possible COVID-19 exposure at Plattsburgh bar – WPTZ

Health officials warn of possible COVID-19 exposure at Plattsburgh bar Updated: 4:45 PM EST Feb 26, 2021 Hide Transcript Show Transcript it's very important to differentiate between a common cold and the coronavirus, especially during a season when the flu is just as prevalent. In case you needed a friendly reminder. Here are some key differences between the common cold and covid 19, according to medical news today, in comparison to the common cold, COVID 19 has a longer potential incubation period, causes more varied symptoms and has a higher risk of complications and fatality, the Times of India r...